Webinar: Assessing Clinical and Economic Benefits of Biocomputational Models

27 March 2012, 09:00 PDST/13:00 EST/18:00 CEST (UTC +02:00).
The economic assessment method described reflects the latest research from the NMS Physiome project, a cooperation of two of the largest global research projects focusing on predictive, personalised and integrative musculoskeletal medicine: the Osteoporotic Virtual Physiological Human (VPHOP) project, and the Center for Physics-based Simulation of Biological Structures (SIMBIOS) at Stanford University.

The Virtual Physiological Human (VPH) is a framework of methods and technologies that, once fully established, is expected to make possible the virtual investigation of the human body as a whole. Started in Europe in 2005, it has rapidly grown to become one of the research priorities of the Information and Communication Technologies Programme of the EU Seventh Framework Programme for Research and Technological Development, which runs from 2007 to 2013. In the US, VPH-type research is funded by all the federal agencies that participate in the Interagency Modeling and Analysis Group (IMAG), whose grantees are coordinated in the Multi-Scale Modeling (MSM) consortium.

NMS Physiome is an international project co-funded by the European Commission Seventh Framework Programme for Research and Technological Development. The Webinar is hosted by SIMBIOS, Stanford University.

How do you assess the impact of biocomputational models?
Karl Stroetmann and Rainer Thiel, empirica Communication and Technology Research, Bonn, Germany.

In this webinar, you will learn about general principles to evaluate the prospective economic and clinical benefits of simulation methods. Webinar organisers will show how this approach enables you to:

  • Assess simulation research and translate technical capability into quantitative estimates of costs and benefits that go beyond model validation
  • Gain a better understanding about the impact such work can have on future health care service delivery and clinical practice
  • Demonstrate the added value of simulation research through clear measures of clinical benefits and the development of business cases
  • More effectively decide what aspects of the model should be included or excluded

The webinar is targeted at biocomputational modellers and researchers as well as RTD funding agencies in the field of Virtual Physiological Human and Physiome.

Duration: 60 minutes.

To register for the event, please visit:
https://stanford.webex.com/stanford/onstage/g.php?d=925320571&t=a

Most Popular Now

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Northern Ireland Completes Nationwide Ro…

Go-lives at Western and Southern health and social care trusts mean every pathology service is using the same laboratory information management system; improving efficiency and quality. An ambitious technology project to...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

Groundbreaking TACIT Algorithm Offers Ne…

Researchers at VCU Massey Comprehensive Cancer Center have developed a novel algorithm that could provide a revolutionary tool for determining the best options for patients - both in the treatment...

The Many Ways that AI Enters Rheumatolog…

High-resolution computed tomography (HRCT) is the standard to diagnose and assess progression in interstitial lung disease (ILD), a key feature in systemic sclerosis (SSc). But AI-assisted interpretation has the potential...